ORGOVYX Support Program

Support to help your patients get started and stay on track

We are dedicated to providing your patients with ongoing support to help them start and continue taking ORGOVYX as prescribed. We know how important it is for patients to stay on track while on treatment. We’re here to help.

ORGOVYX Support Program logo
For more information, call toll-free 1-833-ORGOVYX (1-833-674-6899), Monday-Friday, 8 AM-8 PM ET
Illustration of a clipboard

Reimbursement
Support

We can help assist your patients with access challenges. This includes benefits investigation on patients' insurance coverage, prior authorization assistance through CoverMyMeds®, and appeals support.

Illustration of a pill bottle

ORGOVYX
Free Trial Program*

Eligible patients who are new to ORGOVYX can get up to a 2-month supply of medication at no cost.

Illustration of a calendar representing the Bridge Program

ORGOVYX
Bridge Program

Eligible commercially insured patients who are experiencing coverage issues can receive ORGOVYX at no cost for a limited period of time.

Illustration of a copay card

Financial
Assistance

We offer options to help your eligible patients afford their treatment, including copay assistance for commercially insured patients for as little as $10 per month.

Illustration of a chat box

Nurse
Support

We are here to support your enrolled patients with check-in calls to help answer their questions about treatment.

Illustration of an information symbol

ORGOVYX
Education

We provide educational resources to help support your patients throughout their treatment.

How to enroll your patients:

Illustration of a computer mouse

Log in to your CoverMyMeds® account and submit the ORGOVYX Support Program Start Form online

The CoverMyMeds portal allows pharmacists and providers to initiate, transmit, and track the status of prior authorization (PA) requests and to enroll in the ORGOVYX Support Program. The CoverMyMeds portal helps with:

  • Submitting PA requests to payer
  • Access to drug-specific financial assistance and support for ORGOVYX

Enroll your patients through CoverMyMeds >

Illustration of a fax machine

Print and fax the completed ORGOVYX Support Program Start Form to 1-844-826-8875

Download the ORGOVYX Support Program Start Form >

Illustration of a phone

For more information, call 1-833-ORGOVYX (1-833-674-6899)

Call now >

CoverMyMeds is a registered trademark of CoverMyMeds LLC.

ORGOVYX Support Program is not a CoverMyMeds LLC program or solution. ORGOVYX Support Program is owned and operated solely by Myovant Sciences.

FREE TRIAL PROGRAM

Help your eligible patients start ORGOVYX therapy
Free trial program icon

Eligible patients who have not previously been prescribed ORGOVYX can get up to a 2-month supply at no cost.

The ORGOVYX Free Trial Program is designed to help your eligible patients get started on ORGOVYX. Patients who have not previously been prescribed ORGOVYX can get up to a 2-month supply at no cost. Patients must meet the program eligibility requirements.

For more information, call the 
ORGOVYX Support Program at 1-833-ORGOVYX (1-833-674-6899).

*The ORGOVYX Free Trial Program (FTP) provides an up to 2-month supply of ORGOVYX at no cost to patients who meet FTP eligibility requirements and who agree to the FTP terms and conditions by submitting a signed FTP enrollment form. (i) FTP is a free trial offer, intended solely to allow new patients to try ORGOVYX and to determine with their healthcare provider whether ORGOVYX is right for them. There is no obligation to continue use of ORGOVYX after the free trial has been completed; (ii) to be eligible, patient must: (1) reside in the United States or Puerto Rico and (2) be a new patient not currently using ORGOVYX or who previously received ORGOVYX through the FTP; (iii) ORGOVYX supplied through the FTP will be dispensed only through a pharmacy designated by Myovant Sciences up to the limits above; (iv) product may only be delivered to the patient’s home address (no P.O. boxes) or the prescribing healthcare provider’s office; (v) it is unlawful for any person to sell, purchase, trade, barter or export ORGOVYX supplied through the FTP or make an offer to do so; (vi) ORGOVYX supplied through the FTP may not be billed (in whole or part, directly or indirectly) to any patient or third-party payer, including Medicare, Medicaid and commercial insurance plans; (vii) Myovant Sciences reserves the right to change or discontinue the FTP at any time without notice; (viii) the FTP is not health insurance; (ix) the FTP is not a discount, rebate, coupon, cost-sharing program or other form of financial assistance and no portion of the value of the FTP product may count as a patient out-of-pocket expense under any health insurance program; (x) ORGOVYX supplied free of charge through the FTP is not contingent on continued use of ORGOVYX. To continue a patient on therapy, a separate prescription must be written by the healthcare provider; (xi) the FTP is void where prohibited by law and where use is prohibited by the patient’s insurance provider.

ORGOVYX BRIDGE PROGRAM

The ORGOVYX Bridge Program can help commercially insured patients get access to treatment by providing ORGOVYX at no cost if they are:

  • Experiencing a lapse or delay in coverage
  • Waiting for approval from their insurance provider
Eligible patients may receive ORGOVYX at no cost for a limited period of time.

The ORGOVYX Bridge Program (“Program”) provides ORGOVYX at no cost for a limited period (up to 4 months) to eligible, commercially-insured patients whose insurance coverage is delayed or who experience a temporary lapse in coverage. This Program is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government insurance, or any state patient or pharmaceutical assistance program. Prescribers must complete the Bridge prescription on the start form. By participating, patient acknowledges intent to pursue insurance coverage for ORGOVYX with their health care provider. Program requires the submission of a request for coverage within 9 months post-Program initiation in order to remain eligible. Patients will receive their maintenance drug supply each month for up to 12 months or until they receive insurance coverage approval, whichever occurs earlier. Program is not available to patients who are uninsured or where prohibited by law. Patients may be asked to reverify insurance coverage status during the course of the Program. Patient and participating prescribers agree not to seek reimbursement for all or any part of the benefit received by the patient through this Program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Other limitations may apply. Myovant Sciences reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.

Financial assistance FOR YOUR PATIENTS

For eligible commercially insured patients
Illustration of a copay card

Pay as little as $10 per month

With the ORGOVYX Copay Assistance Program, eligible commercially insured patients pay as little as $10 per month. Learn more about the eligibility criteria for the ORGOVYX Copay Assistance Program by calling 1-833-ORGOVYX (1-833-674-6899).

Enroll patients in the ORGOVYX
Copay Assistance Program

This is a third-party website not controlled by Myovant Sciences.

The ORGOVYX Copay Assistance Program (“Program”) is for eligible patients with commercial prescription insurance for ORGOVYX. The Program is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program. Patient must be a resident of the U.S., Puerto Rico, or U.S. Territories. This Program is void where prohibited by state law. Certain rules and restrictions apply. This card is not insurance. This offer cannot be combined with any other coupon, free trial, discount, prescription savings card, or other offer. Patient and participating pharmacists agree not to seek reimbursement for all or any part of the benefit received by the patient through this Program. Patient and participating pharmacists agree to report the receipt of Program benefits to any insurer or other third party who pays for or reimburses any part of the prescription filled using the Card, as may be required by such insurer or third party. Myovant reserves the right to revoke, rescind, or amend this offer without notice. The Program has no control over the decisions made by, and does not guarantee support from, independent third parties.

For eligible uninsured patients

Through the Myovant Patient Assistance Program, eligible patients may be able to get ORGOVYX at no cost. Learn more about the eligibility criteria for the Myovant Patient Assistance Program by calling 1-833-ORGOVYX (1-833-674-6899).

For Medicare Part D PATIENTS

Your patients may qualify for additional financial support resources. Learn more by calling 1-833-ORGOVYX (1-833-674-6899).

Ordering ORGOVYX

Ordering ORGOVYX for your pharmacy

ORGOVYX is supplied in a bottle containing 30 tablets that are 120 mg each (NDC: 72974-120-01).

ORGOVYX is available to in-office dispensing pharmacies and hospital/academic/institutional specialty pharmacies. ORGOVYX can only be ordered through the authorized specialty distributors below:

ASD

asdhealthcare.com

Email: asd.customerservice@asdhealthcare.com

Phone: 1-800-746-6273

Fax: 1-800-547-9413

Standard Ordering Hours: Monday-Thursday, 8 AM-7:30 PM ET; Friday, 8 AM-7 PM ET

Besse

besse.com

Email: customercare@besse.com

Phone: 1-800-543-2111

Fax: 1-800-543-8695

Standard Ordering Hours: Monday-Thursday, 8:30 AM-7:30 PM ET; Friday, 8:30 AM-5 PM ET

Cardinal Health Specialty Distribution

specialtyonline.cardinalhealth.com (Physician Clinics)

orderexpress.cardinalhealth.com (Hospitals)

Email: gmb-spd-csorderentry@cardinalhealth.com

Phone: 1-855-855-0708

Fax: 1-877-274-9897

Standard Ordering Hours: Monday-Friday 9 AM–7 PM ET

CuraScript SD

curascriptsd.com

Email: customer.service@curascript.com

Phone: 1-877-599-7748

Fax: 1-800-862-6208

Standard Ordering Hours: Monday-Friday, 8 AM-7 PM ET

McKesson Plasma & Biologics (MPB)

connect.mckesson.com

Email: MPBOrders@McKesson.com

Phone: 1-877-625-2566

Standard Ordering Hours: Monday-Friday, 9 AM-7:30 PM ET

McKesson Specialty Health

mscs.mckesson.com

Email: MSH.CustomerCare-MSPL@McKesson.com

Phone: 1-800-482-6700 (Oncology);

Phone: 1-855-477-9800 (Multi-specialty)

Standard Ordering Hours: Monday-Friday, 8 AM-8 PM ET

Oncology Supply

oncologysupply.com

Email: custserv@oncologysupply.com

Phone: 1-800-633-7555

Fax: 1-800-248-8205

Standard Ordering Hours: Monday-Friday, 9 AM-8 PM ET

ORGOVYX prescriptions fulfilled through specialty pharmacies

We have selected 2 URAC and ACHC accredited mail-order specialty pharmacies to provide service nationally to your patients.

These specialty pharmacies can also provide information and resources to your patients, including free delivery, 24-hour access to a pharmacist, ORGOVYX medication counseling, and adherence support.

Biologics by McKesson

biologics.mckesson.com

Phone: 1-800-850-4306

Fax: 1-800-823-4506

Standard Ordering Hours: Monday-Friday 8 AM-8 PM ET

Clinicians are available to speak with patients 24 hours a day, every day.

US Bioservices

usbioservices.com

Phone: 1-877-757-0667

Fax: 1-888-899-0067

Standard Ordering Hours: Monday-Friday 8 AM-8 PM ET

Clinicians are available to speak with patients 24 hours a day, every day.

ACHC=Accreditation Commission for Health Care; URAC=Utilization Review Accreditation Commission.

Myovant Sciences isn't affiliated nor does it recommend the use of any of the listed pharmacies or distributors. It is in the prescriber's discretion to select the appropriate pharmacy or distributor for their specific needs.

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

QT/QTc Interval Prolongation: Androgen deprivation therapy, such as ORGOVYX may prolong the QT/QTc interval. Providers should consider whether the benefits of androgen deprivation therapy outweigh the potential risks in patients with congenital long QT syndrome, congestive heart failure, or frequent electrolyte abnormalities and in patients taking drugs known to prolong the QT interval. Electrolyte abnormalities should be corrected. Consider periodic monitoring of electrocardiograms and electrolytes.

Embryo-Fetal Toxicity: The safety and efficacy of ORGOVYX have not been established in females. Based on findings in animals and mechanism of action, ORGOVYX can cause fetal harm and loss of pregnancy when administered to a pregnant female. Advise males with female partners of reproductive potential to use effective contraception during treatment and for 2 weeks after the last dose of ORGOVYX

Laboratory Testing: Therapy with ORGOVYX results in suppression of the pituitary gonadal system. Results of diagnostic tests of the pituitary gonadotropic and gonadal functions conducted during and after ORGOVYX may be affected. The therapeutic effect of ORGOVYX should be monitored by measuring serum concentrations of prostate-specific antigen (PSA) periodically. If PSA increases, serum concentrations of testosterone should be measured.

Adverse Reactions

Serious adverse reactions occurred in 12% of patients receiving ORGOVYX. Serious adverse reactions in ≥0.5% of patients included myocardial infarction (0.8%), acute kidney injury (0.6%), arrhythmia (0.6%), hemorrhage (0.6%), and urinary tract infection (0.5%). Fatal adverse reactions occurred in 0.8% of patients receiving ORGOVYX including metastatic lung cancer (0.3%), myocardial infarction (0.3%), and acute kidney injury (0.2%). Fatal and non-fatal myocardial infarction and stroke were reported in 2.7% of patients receiving ORGOVYX.

Most common adverse reactions (≥10%) and laboratory abnormalities (≥15%) in patients receiving ORGOVYX were hot flush (54%), glucose increased (44%), triglycerides increased (35%), musculoskeletal pain (30%), hemoglobin decreased (28%), alanine aminotransferase increased (27%), fatigue (26%), aspartate aminotransferase increased (18%), constipation (12%), and diarrhea (12%).

Drug Interactions

Co-administration of ORGOVYX with a P-gp inhibitor increases the area under the curve (AUC) and maximum concentration (Cmax) of ORGOVYX, which may increase the risk of adverse reactions associated with ORGOVYX. Avoid co-administration of ORGOVYX with oral P-gp inhibitors. If co-administration is unavoidable, take ORGOVYX first, separate dosing by at least 6 hours, and monitor patients more frequently for adverse reactions. Treatment with ORGOVYX may be interrupted for up to 2 weeks for a short course of treatment with certain P-gp inhibitors. If treatment with ORGOVYX is interrupted for more than 7 days, resume administration of ORGOVYX with a 360 mg loading dose on the first day, followed by 120 mg once daily.

Co-administration of ORGOVYX with a combined P-gp and strong CYP3A inducer decreases the AUC and Cmax of ORGOVYX, which may reduce the effects of ORGOVYX. Avoid co-administration of ORGOVYX with combined P-gp and strong CYP3A inducers. If co-administration is unavoidable, increase the ORGOVYX dose to 240 mg once daily. After discontinuation of the combined P-gp and strong CYP3A inducer, resume the recommended ORGOVYX dose of 120 mg once daily.

INDICATION

ORGOVYX is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of adult patients with advanced prostate cancer.

Please see full Prescribing Information for ORGOVYX.